MEF2C and neoplasm: Other miRNAs also presented the function of tumor-inhibiting, for instance, miR-233 remarkably slowed the progression of the tumor by repressing myeloid cell differentiation to MDSCs via targeting myocyte enhancer factor 2C (MEF2C) (57).